MedTech Integrates 2020 Track 1


Joining the dots of patient data, diagnosis and decision making is the holy grail for connected health. What is standing in the way? Is MedTech being implemented fast enough, and is “tech for good” a sustainable model?

Welcome and opening remarks

Martino Picardo, Chairman, Discovery Park

An interview with Ben Newton

Global Head of Oncology Solutions GE Healthcare
Interview conducted by Martino Picardo, Chairman, Discovery Park

Gene Genie

Is genome sequencing the catalyst for diagnostics or the rate-limiting step?


GEOFF DAVISON | Chief Executive Officer | Bionow


PAUL JONES | Global Head of Population Genomics | Illumina
TONU ESKO | Professor of Human Genomics at Institute of Genomics | University of Tartu
JO MASON | R&D Director | Yourgene Health
SAMANTHA BRAMLEY | Director of Market Access & Reimbursement | Roche Sequencing Solutions

Clinical Finish

 Whether it is discovered in or delivered to the NHS, is MedTech being implemented fast enough?


HELEN MEESE | Founder & CEO  | The Care Machine


LORNA GREEN | Director of Enterprise & Growth | Innovation Agency
LUELLA TRICKETT | Director, Value & Access | Association of British HealthTech Industries
ARAMINTA LEDGER | Director of Campus Development | Cambridge University Health Partners (CUHP)
KRISTIN POLMAN | Founder | Shine Digital Consulting
ADAM KIRK | Clinical Director | my mhealth

Let’s Connect

Joining the dots of patient data, diagnosis and decision making is the holy grail for connected health. What is standing in the way?


NEIL EBENEZER | Medical Technologist Specialist | Department for International Trade


PAUL ABRAHAMS | Chief Executive Officer | Reacta Biotech
NICK KELLY | Chief Executive Officer | Axela Group
AMER FASIHI | Chief Executive Officer | Kraydel
REBECCA CRALLAN | Head of Cancer Intelligence | Cancer Research UK
GILES TULLY | Chief Executive Officer | PinPoint Data Science
MATTHEW PRIME | Global Medical Director | Roche Diagnostic Information Solutions (DIS)

Tech for good – crossing the boundaries between the developing and developed worlds

Can Medtech with a primary use in the developing world really be a sustainable model?


CERI WILLIAMS | Director of Research and Innovation Development | University of Leeds


ELIZABETH FAIRLEY | Chief Operation Officer | Talking Medicines Limited
WENDY TINDALE | Consultant Clinical Scientist and Scientific & Innovation Director | Sheffield Teaching Hospitals
DAVID JAYNE | Professor of Surgery | University of Leeds
PIETRO VALDASTRI | Chair in Robotics & Autonomous Systems | University of Leeds

Cluster’s last stand

The UK has a MedTech industry to rival the rest of the world, what is the role of clusters in supporting this and how can they strengthen the opportunity for research, innovation and commercialisation?


PHIL CARVIL | HealthTec Cluster Manager | UKRI Science and Technology Facilities Council


DARREN CLARK | Chief Executive | Medilink Midlands
KATH MACKAY | Managing Director | Bruntwood SciTech – Alderley Park
NICKI BROMWICH | Chief Operating Officer | MedCity
BEN MARTYN | Cluster Development Manager | Northern Health Science Alliance (NHSA)
ARUN HARISH | Strategy Director | CPI

Virtual drinks reception sponsored by UKRI Innovate UK

Ian Campbell, Interim Chief Executive, Innovate UK